GlassScriptPhysician profile
Sarah V Boyd
NPI 1528896354
$923.96
in general payments reported to CMS, 2019-2025
17 companies · $854 in 2025
The $854 reported for 2025 was more than what 84% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $69.85 · 2025: $854.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $924.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $923.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $162.27 | 2025 | |
| Renalytix Ai, INC. | $112.37 | 2025 | Kidneyintelx Blood Collection Convenience Kit |
| Bayer Healthcare Pharmaceuticals INC. | $83.45 | 2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $72.13 | 2025 | Caplyta |
| Lilly USA, LLC | $71.35 | 2025 | Kisunla, Zepbound, Mounjaro |
| Astrazeneca Pharmaceuticals LP | $68.31 | 2025 | Airsupra |
| Vertex Pharmaceuticals Incorporated | $54.79 | 2024-2025 | |
| Lundbeck LLC | $51.11 | 2025 | Rexulti |
| Novo Nordisk INC | $45.13 | 2025 | Rybelsus, Ozempic |
| Itamar Medical INC | $44.34 | 2025 | Watchpatone |
| Coastal Medical Technologies LLC | $26.22 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.07 | 2025 | Jardiance |
| Astellas Pharma US INC | $25.69 | 2025 | Veozah |
| Glaxosmithkline, LLC. | $22.56 | 2025 | Trelegy Ellipta |
| Paratek Pharmaceuticals, INC. | $20.97 | 2024 | Nuzyra |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $19.49 | 2024 | Thoratec Heartmate 3 Lvas Implant Kit |
| Exact Sciences Corporation | $17.71 | 2025 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Boyd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.